Investor Overview

There are currently no events to display.

Global - Overview

Aimmune Therapeutics, Inc., is a biopharmaceutical company developing oral treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune’s first investigational, complex biologic product, AR101, is being developed as a treatment to reduce the frequency and severity and ... more >

Recent News

more >

Upcoming Events

more >
There are currently no events to display.

Past Events

Show events starting after a certain date ( i.e. YYYY-MM-DD)
  • Webcast Image Webcast
    J.P. Morgan Healthcare Conference Presentation
    January 10, 2018
    7:30 AM PST
  • Webcast Image Webcast
    BMO Capital Markets: Prescriptions for Success Healthcare Conference
    December 14, 2017
    10:30 AM EST
  • Webcast Image Webcast
    Aimmune Investor Symposium on Peanut Allergy Treatment
    December 01, 2017
    8:00 AM EST
  • Webcast Image Webcast
    Evercore ISI Biopharma Catalyst/Deep Dive Conference
    November 29, 2017
  • Webcast Image Webcast
    29th Annual Piper Jaffray Healthcare Conference
    November 28, 2017
    12:30 PM EST
  • Webcast Image Webcast
    Jefferies London Healthcare Conference
    November 16, 2017
    4:20 AM EST
  • Webcast Image Webcast
    Credit Suisse 26th Annual Healthcare Conference
    November 07, 2017
    3:55 PM MST
  • Webcast Image Webcast
    Aimmune Therapeutics Conference Call
    October 16, 2017
    8:30 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Cantor Fitzgerald Global Healthcare Conference
    September 26, 2017
    9:10 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Bank of America Merrill Lynch Global Healthcare Conference
    September 15, 2017
    5:40 AM EDT